Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, V. L.
Right arrow Articles by Lee, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, V. L.
Right arrow Articles by Lee, W. R.
[Cancer Research 60, 1830-1834, April 1, 2000]
© 2000 American Association for Cancer Research


Advances in Brief

Oncogenic Base Substitution Mutations in Circulating Leukocytes of Normal Individuals1

Vincent L. Wilson2, Xiuqin Yin, Barbara Thompson, Kerry R. Wade, Jeremy P. Watkins, Qi Wei and William R. Lee

Institute of Environmental Studies [V. L. W., X. Y., B. T., K. R. W., J. P. W.] and Institute for Mutagenesis and the Department of Biological Sciences [V. L. W., X. Y., B. T., K. R. W., J. P. W., W. R. L.], Louisiana State University, Baton Rouge, Louisiana 70803, and The Children’s Hospital, Denver, Colorado 80516 [Q. W.]

The background frequency of mutations in human tissues is an important issue in cancer susceptibility and genotoxic exposure determinations. Here we report the detection of rare mutant leukocytes containing oncogenic base substitutions of the Harvey-ras, N-ras, and p53 genes by the Needle-in-a-Haystack mutation assay with a sensitivity of one cell in a million. Altogether, we detected and identified 17 independent mutations of 66 separate base site analyses of peripheral blood specimens obtained from 19 apparently normal individuals. Two individuals harbored a substantially increased frequency of mutant cells, representing 9 of the 17 independent mutations found. These results suggest that up to 1 in 10 normal individuals may harbor a significant frequency of oncogenic mutations in circulating leukocytes.




This article has been cited by other articles:


Home page
BloodHome page
D. T. Bowen, M. E. Frew, R. Hills, R. E. Gale, K. Wheatley, M. J. Groves, S. E. Langabeer, P. D. Kottaridis, A. V. Moorman, A. K. Burnett, et al.
RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years
Blood, September 15, 2005; 106(6): 2113 - 2119.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. S. Kim and W. G. Thilly
Ligation of high-melting-temperature 'clamp' sequence extends the scanning range of rare point-mutational analysis by constant denaturant capillary electrophoresis (CDCE) to most of the human genome
Nucleic Acids Res., August 15, 2003; 31(16): e97 - e97.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Kaur and G. M. Makrigiorgos
Novel amplification of DNA in a hairpin structure: towards a radical elimination of PCR errors from amplified DNA
Nucleic Acids Res., March 15, 2003; 31(6): e26 - e26.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.